DistillerSR Evidence Matters LinkedIn Newsletter: August 15, 2022

Save your seat: Evidence Matters' 22 is September 27, 2022

Join us on September 27 at 10 am EST for the 2022 edition of DistillerSR's annual literature review summit, Evidence Matters' 22. This complimentary virtual one-day summit brings together some of the world's most insightful experts, allowing attendees to engage with peers, learn best practices, and solve ever-pressing evidence-based research challenges.

Keynote Speaker: Dr. Devi Sridhar

Chair & Professor of Public Health at the University of Edinburgh

Dr. Devi Sridhar is a professor at the University of Edinburgh where she holds a personal chair in global public health. She is the founding director of the Global Health Governance Programme and holds a Welcome Trust Investigator Award. Dr. Sridhar also serves as a member of the Scottish Government’s COVID-19 advisory group, set up to provide advice on how to deal with the COVID-19 pandemic in Scotland.

Recipient of a Rhodes Scholarship, Devi holds an MPhil and a DPhil from Oxford University as well as a B.S. from the University of Miami’s Honors Medical Program. Prior to her appointment at Edinburgh, she was a postdoctoral research fellow at All Souls College, Oxford University, and an associate professor in Global Health Politics and Fellow at Wolfson College, Oxford University.

Dr. Devi is the author of four books, including?Preventable: How a Pandemic Changed the World & How to Stop the Next One ,?Governing Global Health: Who Runs the World and Why??(OUP, 2017) and?The Battle Against Hunger: Choice, Circumstance and the World Bank?(OUP, 2007). She has published her work in Nature, Science, the New England Journal of Medicine, The Lancet, and The British Medical Journal.

Keynote Speaker: Dr. Jessica Shen

Vice-President of Global MedTech Sector, Preclinical, Clinical Medical Strategy & Operations at Johnson & Johnson?

Dr. Jessica Shen is the vice-president of global MedTech sector preclinical, clinical medical strategy & operations at Johnson & Johnson. Previously, Dr. Shen served as senior vice-president and vice-president in regulatory affairs, medical & clinical affairs, health economics, and outcomes research (HEOR) at Royal Philips. She also served as a board member at PolarityTE, a biotechnology company developing regenerative tissue products. In addition to Dr. Shen's more than 20 years of clinical and regulatory experience in roles at Johnson & Johnson, Royal Philips, and Abbott Laboratories, she has participated in professional development programs at MIT Sloan Business School as well as Harvard Business School. She has been credited with a multitude of publications, has helped secure US Department of Defense research grants, and has received numerous awards and accolades, including the Johnson Medal.

EM'22 Industry Breakout Sessions Speakers:

Medical Devices, Public Sector, Health Economics Outcomes Research (HEOR), and Pharmacovigilance (PV)

Industry Best Practices Track Breakouts speakers include DistillerSR customers from Sanofi, Integra LifeSciences, Roche, Canadian Association of Radiologists, Public Health Agency of Canada (PHAC), Excerpta Medica, Maple Health Group, and industry experts, such as Dr. Patti Peeples and more.

NEW at EM'22: Introducing a new industry best practices track focused on pharmacovigilance (PV) with DistillerSR customers ICON and SpringWorks.

DistillerSR Innovation Breakout Sessions

Learn from DistillerSR experts about:

• Solving Complex Customer Data Migration Projects
• Supporting Living Reviews with PRISMA 2020
• Data Reuse Using CuratorCR
• Systematic Literature Review Data Visualization

We look forward to your participation!

Evidence Matters' 21 Recap

Did you miss EM'21? Watch all the sessions that made this virtual summit a day of insightful discussions, valuable exchanges from industry leaders and provided the audience with an exclusive glance into DistillerSR's roadmap to help customers conduct literature reviews faster and more accurately.

• How COVID-19 Has Shifted Our Understanding and Application of Scientific Evidence - Dr. David Nash, Founding Dean Emeritus at the Jefferson College of Population Health outlined how misinformation has the power to impact our world and affect people's perception of evidence and science.
• Managing CERs and PERs Programatically to Meet EU Regulatory Requirements Regulatory expert Dr. Bassil Akra and Dr. Julien Senac from TüV SüD discussed with DistillerSR customers Medtronic and Philips how to navigate the MDR/IVDR compliance path leveraging innovative technology.
• Applying Systematic Reviews to Real-World Evidence (RWE) Study Design Dr. Patti Peeples led a conversation with DistillerSR customers Dr. Michael Broder and Jesse Ortendahl from Partnership for Health Analytics Research (PHAR) on the evolution of the healthcare industry for physicians, insurers, pharmaceutical companies and patients as a result of real-world evidence (RWE).
• The Importance of Evidence-Based Research for the Public Sector Ecosystem DistillerSR customer Dr. Katya Tsaioun from Johns Hopkins Bloomberg School of Public Health and Michelle Fleetwood, Solutions Consultant at Clarivate explored how automated solutions have enabled collaboration for distributed teams working on large systematic review projects while keeping up with the unprecedented pace of evidence-based research.
• Automation Can Be Your Best Friend: Streamlining Every Stage of Your Reviews Take a deep dive into how to evolve from an error-prone literature review process to an AI-powered process that enables scalability, collaboration for distributed teams, efficient project management and accurate reporting.

EM'22 Partners

Thank you for reading! Like what you see? Subscribe and keep up with Evidence Partners' mission to change the way scientific research is conducted!

Did you find this newsletter helpful or interesting? Let us know your comments and thoughts below.